Bio-Rad Laboratories Profit Margin

Bio-Rad Laboratories (BIO) currently reports a profit margin of 6.52% as of March 2026. That compares with -87.68% in the prior-year period — up 107.4% year over year. That is below the Healthcare sector average of 15.58%. Use the charts on this page to explore Bio-Rad Laboratories's profit margin history and peer comparisons.

Bio-Rad Laboratories's profit margin increased from -87.68% to 6.52% — a 107.4% year-over-year increase (period ending March 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Bio-Rad Laboratories's profit margin of 6.52% is lower than the Healthcare sector average of 15.58%. That is roughly 58.2% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

There is no universal 'good' profit margin, but Bio-Rad Laboratories's current 6.52% should be judged against Healthcare norms (sector average: 15.58%) and against BIO's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.

Start with the current profit margin of 6.52%, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 15.58%. From there, open related valuation or income-statement pages for Bio-Rad Laboratories, and consider following BIO for alerts when major investors trade the stock.